Author:
Ettl Johannes,Weyrich Joy,Krämer Anne
Publisher
Springer Berlin Heidelberg
Reference15 articles.
1. Balmelli C, Hofer S, Conen K (2016) Maligne Hyperkalzämie. Schweiz Med Forum 16(47):1012–1018
2. Crawford J, Dale DC, Lyman GH (2004) Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer. 100(2):228–237
3. Du Bois S, Kümmel S, Herter P (2019) Standards der systemischen Therapie 2019 bei gynäkologischen Tumoren inklusive des Mammakarzinoms – Klinik für Gynäkologie & Gyn. Onkologie, Klinik für Senologie Essen Mitte, 2/2019
4. Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guidelines for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis:52
5. Heinz WJ, Buchheidt D, Christopeit M et al (2017) Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 96:1775–1792